Home › Blood Disorders › Alabama
Blood Disorders clinical trials in Alabama
5 studies for Blood Disorders are looking for participants at sites in Alabama.
Cities in Alabama
A Study to Investigate the Efficacy and Safety of Crizanlizumab (5 mg/kg) Compared With Placebo in Adolescent and Adult Sickle Cell Disease Patients Who Experience Frequent Vaso-Occlusive Crises (SPARKLE)
- University Of Alabama, Birmingham
RecruitingPhase 3
Ages 12 to 100 · All sexes · Updated Sep 28, 2026 · NCT06439082Pivotal Open-label Phase 3 Clinical Study of QTX-2101 in Adult Patients With Acute Promyelocytic Leukemia
- Quetzal Site 16, Birmingham
RecruitingPhase 3
Ages 18 to 71 · All sexes · Updated Sep 23, 2026 · NCT07504458BMT-CARE: Psychosocial Intervention for Transplant Caregivers
- University of Alabama at Brimingham, Birmingham
Recruiting
Ages 18 and older · All sexes · Updated Oct 15, 2025 · NCT06472089Study of VIP943 in Subjects With Advanced CD123+ Hematologic Malignancies
- University of Alabama at Birmingham, Birmingham
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Nov 15, 2024 · NCT06034275Collection and Distribution of Biospecimens for Novel Research Uses
- iSpecimen, Huntsville
RecruitingObservational studyHealthy volunteers welcome
1 Month – 89 Years · All sexes · Updated Nov 9, 2022 · NCT03848962From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.